Answers are grounded in this paper and cite their sources.
Chronic kidney disease (CKD) coexists in up to 50% of heart failure (HF) patients, affecting both those with reduced ejection fraction (HFrEF) and those with preserved ejection fraction (HFpEF). Although the efficacy of several guideline-directed medical therapies (GDMT) has been well established, the treatment recommendations are similar for those patients with HF with and without CKD. We aimed to investigate the efficacy of GDMT in patients with HF with versus those without CKD.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: